[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-biolife-solutions-inc-nasdaqbl3301938045-df2e-7805-83ff-a3f16e023429":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":23,"enrichStatus":19,"triageKind":18,"triageImportance":18,"expandEligible":18,"summarizeEligible":18,"eventEligible":18,"eventType":18,"eventAction":18},"biolife-solutions-inc-nasdaqbl3301938045-df2e-7805-83ff-a3f16e023429","1733022971000","BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells $14,225.60 in Stock","BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 523 shares of the company's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $27.20, for a total transaction of $14,225.60. Following the completion of the sale, the executive vice president now owns 283,919 shares in the company, valued at approximately $7,722,596.80. This trade represents a 0.18 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.","https://www.marketbeat.com/instant-alerts/biolife-solutions-inc-nasdaqblfs-evp-sells-1422560-in-stock-2024-11-29/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"-\"]","[{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","1"]